A federal appeals court has ordered the Drug Enforcement Administration to respond to a complaint that it has failed to timely act on an application by a firm to become a bulk manufacturer of cannabis for use in clinical trials (In re Scottsdale Research Institute, L.L.C., No. 19-1120 (D.C. Cir. July 29, 2019)). Scottsdale Research Institute LLC (SRI) of Arizona petitioned the Dist... Read More